A Whistle-Blower’s Quandary [Chapter 4, Case 4.3, pp. 86-88]As a vice-president for Pharmacia (which was acquired by Pfizer in 2003), Dr. Peter Rost was in charge of worldwide marketing for the drug Genotropin, which is a synthetic human growth hormone that is used to treat a limited range of hormonal deficiencies in children and the elderly
Read the case study as presented, and address the following.
1. Summarize the case, and describe the participants.
2. How are diverse dynamics of ethics in the organization reflected in this case study?
3. Describe at least two ethical theories that can be related to this case study.
4. Define the concept of whistle blower, and research and discuss the lessons of real cases of whistle blower.
5. Discuss the implications of the case with relationship to discrimination and Affirmative Action.
6. Discuss the implications of the case with relationship trade secrets and conflict of interest.
7. Use a minimum of two references from business ethics journals.
8. Submit the paper following APA standards.
9. Use the traditional introduction, body, and conclusion outline.
CASE 4.3 A Whistle-Blower’s Quandary
As a vice-president for Pharmacia (which was acquired by Pfizer in 2003), Dr. Peter Rost was in charge of worldwide marketing for the drug Genotropin, which is a synthetic human growth hormone that is used to treat a limited range of hormonal deficiencies in children and the elderly. 42 Beginning in 1997 and continuing to 2003, Pharmacia aggressively promoted Genotropin for conditions beyond those for which the drug had received approval from the Food and Drug Administration (FDA). Physicians may legally prescribe an FDA-approved drug for such “offlabel” use, but pharmaceutical companies are strictly prohibited from any promotional activities designed to encourage physicians to prescribe a drug for any but approved uses. However, Pharmacia attempted to persuade physicians to prescribe Genotropin for short children without any hormonal deficiency as well as for elderly patients as an antiaging therapy. Among the means used to increase prescriptions were kickbacks to physicians in the form of all-expense-paid company-sponsored conferences, paid participation in drug studies, and lucrative consulting positions. These efforts produced results. During the period 1997 to 2003, approximately 25percent of all prescriptions for children and 60 percent of prescriptions for adults were for off-label use.
PLACE THIS ORDER OR A SIMILAR ORDER WITH NURSING TERM PAPERS TODAY AND GET AN AMAZING DISCOUNT
